Spend on new drugs expected to drop


The drugs industry expects the NHS to cut its real terms spend on new medicines over the next three years - but it is warning that the slow adoption of new drugs could create avoidable costs.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here